Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lonza Group AG

LONN.S ✓ COMPLIANT ☆ Track — members

SIX Swiss · Healthcare · Biotechnology & Medical Research ·

Switzerland Large Cap Analyst: BUY

Last Close

$700.68

▼ -2.54%

Market Cap $49.33B · Vol 96.08K

Key Metrics

P/E Ratio

37.75

FWD: 29.67

Market Cap

$49.33B

Large Cap

Div Yield

0.88%

Dividend with no set frequency

EPS Growth

+15.51%

YoY

RSI (14)

50.51

Momentum

Beta

1.21

vs Market

52W High

$738.48

8.08% below

52W Low

$561.58

21.18% above

Volume

96.08K

Avg 116.31K

P/B

4.75

Price-to-book

ROE

11.40%

Return on equity

Free Float

99.91%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Lonza Group AG (LONN.S) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LONN.S pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.84%

+1.94%

+15.43%

+7.91%

YTD

+5.47%

-1.90%

+26.05%

-26.22%

Financials & Valuation

TTM · Annual

Total Revenue	$8.24B
Net Income	$1.15B
Revenue Growth (YoY)	+11.21%
Gross Margin	54.25%
Operating Margin	41.85%
Net Profit Margin	13.92%
ROE	11.40%
ROA · ROIC	5.85% · -1.05%

P/E Ratio	37.75
Forward P/E (FY1)	29.67
PEG Ratio	0.77
P/S	5.77
P/B	4.75
P/FCF	N/A
EPS Growth	+15.51%
Outstanding Shares	70.23M

Technical Indicators

50-Day SMA	$705.43
200-Day SMA	$654.37
RSI (14)	50.51
Beta	1.21
52-Week High	$738.48
52-Week Low	$561.58

Volume Today	96.08K
Avg Daily Volume (30D)	116.31K
Relative Volume	0.83x
Volatility (10D)	16.27
Volatility (30D)	19.69
Free Float	99.91%

Analyst Consensus

BUY

Current Price $700.68

Mean Target $845.22

52W Low$561.58 52W High$738.48

Current

Target

$561.58 $738.48

Current Analyst target

+20.63% upside potential · 25 analysts

Identifiers

ExchangeSIX Swiss

FIGIBBG001SDFZX8

ISINCH0013841017

CountrySwitzerland

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateJan 26, 2027

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

RVMD Revolution Medicines Inc -0.40% ONC BeOne Medicines AG -1.22% 068270.KS Celltrion Inc +0.53% ABVX Abivax SA +0.66% ABVX.PA Abivax SA -1.56%

Company Profile

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.